"Therefore I don't see having 250mil on hand as a bad thing."
Well I guess that's progress, of a kind.
So finally, the thing you are now saying is it all depends on the outcomes of the science.
Have you looked into MSB's record on that at all? Because your posts make it seem like it's an unknown bet.
Whereas looking at the science, and the record of MSB in clinical trials so far is a valuable piece of research. As Vinn has said many times, but for whatever reason, people choose to ignore, MSB hasn't had a negative ann on this.
Do you think this adds to MSB's credibility?
Glad we aren't still talking about C/Rs anymore. At least that red herring is off the list.
Geez, it's like pulling out teeth.
MSB Price at posting:
$4.79 Sentiment: LT Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)